We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.44B
AUM Growth
+$71.4M
Cap. Flow
-$5.26M
Cap. Flow %
-0.22%
Top 10 Hldgs %
47.84%
Holding
319
New
22
Increased
148
Reduced
94
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 12.77%
2 Healthcare 7.71%
3 Financials 5.22%
4 Industrials 4.55%
5 Communication Services 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$4.08T
$17.7M 0.73%
170,852
+5,941
+4% +$570K
RF icon
27
Regions Financial
RF
$26.3B
$17.4M 0.71%
939,930
-9,748
-1% -$212K
ACN icon
28
Accenture
ACN
$99.9B
$17.3M 0.71%
60,671
+2,311
+4% +$630K
XLB icon
29
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$17M 0.7%
420,974
+367,568
+688% +$14.9M
SCHW
30
Charles Schwab
SCHW
$181B
$16.7M 0.68%
318,598
+226,157
+245% +$16.6M
EMR icon
31
Emerson Electric
EMR
$83.3B
$16.5M 0.68%
189,666
+8,481
+5% +$741K
INTC icon
32
Intel
INTC
$460B
$16.1M 0.66%
493,315
-30,819
-6% -$873K
QCOM icon
33
Qualcomm
QCOM
$159B
$15.6M 0.64%
122,186
-3,062
-2% -$381K
META icon
34
Meta Platforms (Facebook)
META
$1.37T
$15.6M 0.64%
73,477
+30,928
+73% +$5.27M
CVS icon
35
CVS Health
CVS
$134B
$15.4M 0.63%
206,647
+134,493
+186% +$11.3M
ABBV icon
36
AbbVie
ABBV
$455B
$15.1M 0.62%
94,607
+3,223
+4% +$493K
RHI icon
37
Robert Half
RHI
$3.81B
$15.1M 0.62%
187,131
+6,771
+4% +$537K
JNJ icon
38
Johnson & Johnson
JNJ
$617B
$14.7M 0.6%
94,711
+12,027
+15% +$1.94M
V icon
39
Visa
V
$684B
$14.2M 0.58%
63,102
+370
+0.6% +$82.4K
AMZN icon
40
Amazon
AMZN
$2.53T
$13.8M 0.57%
133,838
+18,103
+16% +$1.75M
MDT icon
41
Medtronic
MDT
$110B
$13.7M 0.56%
170,245
+15,475
+10% +$1.26M
ADBE icon
42
Adobe
ADBE
$98.5B
$13.6M 0.56%
35,283
+13,365
+61% +$4.75M
AMD icon
43
Advanced Micro Devices
AMD
$791B
$13.5M 0.55%
137,238
-17,314
-11% -$1.41M
INCY icon
44
Incyte
INCY
$24.9B
$13.4M 0.55%
185,191
-10,224
-5% -$800K
NVS icon
45
Novartis
NVS
$301B
$12.8M 0.52%
139,088
-3,603
-3% -$315K
SYY icon
46
Sysco
SYY
$40.6B
$12.6M 0.52%
163,725
-4,635
-3% -$356K
EOG icon
47
EOG Resources
EOG
$77.5B
$12.5M 0.51%
108,627
+3,293
+3% +$399K
BIIB icon
48
Biogen
BIIB
$30.7B
$12.4M 0.51%
44,488
-1,547
-3% -$428K
LULU icon
49
lululemon athletica
LULU
$13.6B
$12.2M 0.5%
33,555
-547
-2% -$171K
AMAT icon
50
Applied Materials
AMAT
$398B
$11.5M 0.47%
93,636
-13,095
-12% -$1.5M

Similar funds

Grimes & Company's Q1 2023 Portfolio in Review

As of Q1 2023, Grimes & Company held 319 positions worth $2.44B, up 3% from $2.37B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company's Q1 2023 filing shows 22 new, 148 increased, 94 reduced and 14 closed positions. Its largest new stake was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2023 buy was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2023, an estimated $225M increase.
  • Grimes & Company's biggest Q1 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $349M.
  • Grimes & Company fully exited SVB Financial Group in Q1 2023, selling an estimated $5.35M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.44B portfolio in Q1 2023.
  • Grimes & Company opened 22 new positions and closed 14 in Q1 2023.
  • Grimes & Company's portfolio value rose 3% quarter-over-quarter to $2.44B.

Based on Grimes & Company's 13F filing for Q1 2023, filed 20 Apr 2023.